Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)
Rethinking Clinical Trials
FEBRUARY 7, 2024
The research yielded a report that provides 5 observations, 16 potential strategies, and more than 40 potential tactics for the FDA to consider. This work is important because the digital health information environment and limited public trust in government institutions represent pressing challenges for FDA.
Let's personalize your content